Literature DB >> 21107854

Current concepts of organ preservation in head and neck cancer.

C-J Wang1, R Knecht.   

Abstract

The treatment of laryngeal and hypopharyngeal cancer nowadays is not limited by surgical resection. There are many interdisciplinary approaches which we can offer these patients in our clinics. These include radiotherapy, chemotherapy, biologicals and surgery. The combination of radiotherapy, chemotherapy, biologicals and surgery techniques more and more allows us to perform organ and function preservation in a former often mutilating and function destroying treatment. Since the early 1990s, evidence from large randomized trials has shown that organ preservation studies using sequential and concomitant radio-chemotherapy do not compromise survival when compared with surgery followed by radiotherapy. However, using these therapies side effects have to be taken into consideration and not organ preservation but function preservation is the treatment goal. The current most common treatment options are shown here in this review. For future treatment protocols there is an urgent need to refine the definition of a functional organ, to define quality of life endpoints and to refine the recommendations for evaluating treatment response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107854     DOI: 10.1007/s00405-010-1407-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  46 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Jean Bourhis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

3.  Transoral robotic surgery (TORS) for base of tongue neoplasms.

Authors:  Bert W O'Malley; Gregory S Weinstein; Wendy Snyder; Neil G Hockstein
Journal:  Laryngoscope       Date:  2006-08       Impact factor: 3.325

4.  Organ preservation by transoral laser microsurgery in piriform sinus carcinoma.

Authors:  W Steiner; P Ambrosch; C F Hess; M Kron
Journal:  Otolaryngol Head Neck Surg       Date:  2001-01       Impact factor: 3.497

5.  Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.

Authors:  C A Mantz; E E Vokes; M S Kies; B Mittal; M E Witt; M A List; R R Weichselbaum; D J Haraf
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

6.  Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.

Authors:  M R Posner; C M Norris; L J Wirth; D M Shin; K J Cullen; E W Winquist; C R Blajman; E A Mickiewicz; G P Frenette; L F Plinar; R B Cohen; L M Steinbrenner; J M Freue; V A Gorbunova; S A Tjulandin; L E Raez; D R Adkins; R B Tishler; M R Roessner; R I Haddad
Journal:  Ann Oncol       Date:  2009-01-29       Impact factor: 32.976

7.  Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.

Authors:  Xavier Dufour; Stéphane Hans; Erwan De Mones; Daniel Brasnu; Madeleine Ménard; Ollivier Laccourreye
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-09

8.  National Cancer Database report on cancer of the head and neck: 10-year update.

Authors:  Jay S Cooper; Kim Porter; Katherine Mallin; Henry T Hoffman; Randal S Weber; Kian K Ang; E Greer Gay; Corey J Langer
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

Review 9.  Current and emerging standards of concomitant chemoradiotherapy.

Authors:  David J Adelstein; Cristina P Rodriguez
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

10.  Factors predictive of survival in advanced laryngeal cancer.

Authors:  Amy Y Chen; Michael Halpern
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12
View more
  4 in total

Review 1.  Targeted therapy in head and neck cancer.

Authors:  S K Kundu; M Nestor
Journal:  Tumour Biol       Date:  2012-02-29

2.  Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.

Authors:  Traci R Tuttle; Vinita Takiar; Bhavna Kumar; Pawan Kumar; Nira Ben-Jonathan
Journal:  Cancer Lett       Date:  2016-12-23       Impact factor: 8.679

3.  Systemic therapy strategies for head-neck carcinomas: Current status.

Authors:  Thomas K Hoffmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

4.  Multimodality and Sequential Therapy in Locally Advanced Head and Neck Cancer: A Preface to the Special Issue.

Authors:  Giuseppe Riva; Giancarlo Pecorari
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.